Exact Mass: 571.3005836
Exact Mass Matches: 571.3005836
Found 391 metabolites which its exact mass value is equals to given mass value 571.3005836
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Endomorphin-2
Endomorphin-1 (H-Tyr-Pro-Trp-Phe-NH2) and endomorphin-2 (H-Tyr-Pro-Phe-Phe-NH2) are peptide amides with the highest known affinity and specificity for the mu-opioid receptor. [HMDB] Endomorphin-1 (H-Tyr-Pro-Trp-Phe-NH2) and endomorphin-2 (H-Tyr-Pro-Phe-Phe-NH2) are peptide amides with the highest known affinity and specificity for the mu-opioid receptor. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
Kinetensin 4-7
Kinetensin 4-7 is a fraction of kinetensin with only the Arg-His-Pro-Tyr peptide chain. Kinetensin is a nonapeptide, originally isolated from pepsin-treated plasma that shares some sequence homology with the C-terminal end of neurotensin, serum albumin, and angiotensin. It is a potent histamine releaser in rodents and may serve as an inflammatory mediator. Kinetensin 4-7 is a fraction of Kinetensin with only Arg-His-Pro-Tyr peptide chain.
(1S,5R)-5-{(1E,3E)-5-[(2S,3S,5R,6R)-5-{[(2Z,4S)-4-(acetyloxy)pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl]-3-methylpenta-1,3-dien-1-yl}-1,5-anhydro-1-(carboxymethyl)-3-C-(chloromethyl)-2-deoxypentitol
C28H42ClNO9 (571.2547952000001)
Phe Ile His Arg
Ser Phe Tyr Arg
Ala Arg Tyr Tyr
Ala Tyr Arg Tyr
Ala Tyr Tyr Arg
Cys Phe Phe Arg
Cys Phe Arg Phe
Cys Arg Phe Phe
Asp Phe Lys Tyr
Asp Phe Tyr Lys
Asp Lys Phe Tyr
Asp Lys Tyr Phe
Asp Tyr Phe Lys
Asp Tyr Lys Phe
Glu His Met Arg
Glu His Arg Met
Glu Met His Arg
Glu Met Arg His
Glu Arg His Met
Glu Arg Met His
Phe Cys Phe Arg
Phe Cys Arg Phe
Phe Asp Lys Tyr
Phe Asp Tyr Lys
Phe Phe Cys Arg
Phe Phe Lys Met
Phe Phe Met Lys
Phe Phe Arg Cys
Phe His Ile Arg
Phe His Leu Arg
Phe His Arg Ile
Phe His Arg Leu
Phe Ile Arg His
Phe Lys Asp Tyr
Phe Lys Phe Met
Phe Lys Met Phe
Phe Lys Tyr Asp
Phe Leu His Arg
Phe Leu Arg His
Phe Met Phe Lys
Phe Met Lys Phe
Phe Arg Cys Phe
Phe Arg Phe Cys
Phe Arg His Ile
Phe Arg His Leu
Phe Arg Ile His
Phe Arg Leu His
Phe Arg Ser Tyr
Phe Arg Tyr Ser
Phe Ser Arg Tyr
Phe Ser Tyr Arg
Phe Tyr Asp Lys
Phe Tyr Lys Asp
Phe Tyr Arg Ser
Phe Tyr Ser Arg
His Glu Met Arg
His Glu Arg Met
His Phe Ile Arg
His Phe Leu Arg
His Phe Arg Ile
His Phe Arg Leu
His Ile Phe Arg
His Ile Arg Phe
His Leu Phe Arg
His Leu Arg Phe
His Met Glu Arg
His Met Arg Glu
His Met Val Trp
His Met Trp Val
His Pro Arg Tyr
His Pro Tyr Arg
His Arg Glu Met
His Arg Phe Ile
His Arg Phe Leu
His Arg Ile Phe
His Arg Leu Phe
His Arg Met Glu
His Arg Pro Tyr
His Arg Tyr Pro
His Val Met Trp
His Val Trp Met
His Trp Met Val
His Trp Val Met
His Tyr Pro Arg
His Tyr Arg Pro
Ile Phe His Arg
Ile Phe Arg His
Ile His Phe Arg
Ile His Arg Phe
Ile Asn Tyr Tyr
Ile Arg Phe His
Ile Arg His Phe
Ile Tyr Asn Tyr
Ile Tyr Tyr Asn
Lys Asp Phe Tyr
Lys Asp Tyr Phe
Lys Phe Asp Tyr
Lys Phe Phe Met
Lys Phe Met Phe
Lys Phe Tyr Asp
Lys Met Phe Phe
Lys Val Tyr Tyr
Lys Tyr Asp Phe
Lys Tyr Phe Asp
Lys Tyr Val Tyr
Lys Tyr Tyr Val
Leu Phe His Arg
Leu Phe Arg His
Leu His Phe Arg
Leu His Arg Phe
Leu Asn Tyr Tyr
Leu Arg Phe His
Leu Arg His Phe
Leu Tyr Asn Tyr
Leu Tyr Tyr Asn
Met Glu His Arg
Met Glu Arg His
Met Phe Phe Lys
Met Phe Lys Phe
Met His Glu Arg
Met His Arg Glu
Met His Val Trp
Met His Trp Val
Met Lys Phe Phe
Met Arg Glu His
Met Arg His Glu
Met Val His Trp
Met Val Trp His
Met Trp His Val
Met Trp Val His
Asn Ile Tyr Tyr
Asn Leu Tyr Tyr
Asn Pro Arg Trp
Asn Pro Trp Arg
Asn Arg Pro Trp
Asn Arg Trp Pro
Asn Trp Pro Arg
Asn Trp Arg Pro
Asn Tyr Ile Tyr
Asn Tyr Leu Tyr
Asn Tyr Tyr Ile
Asn Tyr Tyr Leu
Pro His Arg Tyr
Pro His Tyr Arg
Pro Asn Arg Trp
Pro Asn Trp Arg
Pro Arg His Tyr
Pro Arg Asn Trp
Pro Arg Trp Asn
Pro Arg Tyr His
Pro Trp Asn Arg
Pro Trp Arg Asn
Pro Tyr His Arg
Pro Tyr Arg His
Gln Val Tyr Tyr
Gln Tyr Val Tyr
Gln Tyr Tyr Val
Arg Ala Tyr Tyr
Arg Cys Phe Phe
Arg Glu His Met
Arg Glu Met His
Arg Phe Cys Phe
Arg Phe Phe Cys
Arg Phe His Ile
Arg Phe His Leu
Arg Phe Ile His
Arg Phe Leu His
Arg Phe Ser Tyr
Arg Phe Tyr Ser
Arg His Glu Met
Arg His Phe Ile
Arg His Phe Leu
Arg His Ile Phe
Arg His Leu Phe
Arg His Met Glu
Arg His Pro Tyr
Arg His Tyr Pro
Arg Ile Phe His
Arg Ile His Phe
Arg Leu Phe His
Arg Leu His Phe
Arg Met Glu His
Arg Met His Glu
Arg Asn Pro Trp
Arg Asn Trp Pro
Arg Pro His Tyr
Arg Pro Asn Trp
Arg Pro Trp Asn
Arg Pro Tyr His
Arg Ser Phe Tyr
Arg Ser Tyr Phe
Arg Trp Asn Pro
Arg Trp Pro Asn
Arg Tyr Ala Tyr
Arg Tyr Phe Ser
Arg Tyr His Pro
Arg Tyr Pro His
Arg Tyr Ser Phe
Arg Tyr Tyr Ala
Ser Phe Arg Tyr
Ser Arg Phe Tyr
Ser Arg Tyr Phe
Ser Tyr Phe Arg
Ser Tyr Arg Phe
Val His Met Trp
Val His Trp Met
Val Lys Tyr Tyr
Val Met His Trp
Val Met Trp His
Val Gln Tyr Tyr
Val Trp His Met
Val Trp Met His
Val Tyr Lys Tyr
Val Tyr Gln Tyr
Val Tyr Tyr Lys
Val Tyr Tyr Gln
Trp His Met Val
Trp His Val Met
Trp Met His Val
Trp Met Val His
Trp Asn Pro Arg
Trp Asn Arg Pro
Trp Pro Asn Arg
Trp Pro Arg Asn
Trp Arg Asn Pro
Trp Arg Pro Asn
Trp Val His Met
Trp Val Met His
Tyr Ala Arg Tyr
Tyr Ala Tyr Arg
Tyr Asp Phe Lys
Tyr Asp Lys Phe
Tyr Phe Asp Lys
Tyr Phe Lys Asp
Tyr Phe Arg Ser
Tyr Phe Ser Arg
Tyr His Pro Arg
Tyr His Arg Pro
Tyr Ile Asn Tyr
Tyr Ile Tyr Asn
Tyr Lys Asp Phe
Tyr Lys Phe Asp
Tyr Lys Val Tyr
Tyr Lys Tyr Val
Tyr Leu Asn Tyr
Tyr Leu Tyr Asn
Tyr Asn Ile Tyr
Tyr Asn Leu Tyr
Tyr Asn Tyr Ile
Tyr Asn Tyr Leu
Tyr Pro His Arg
Tyr Pro Arg His
Tyr Gln Val Tyr
Tyr Gln Tyr Val
Tyr Arg Ala Tyr
Tyr Arg Phe Ser
Tyr Arg His Pro
Tyr Arg Pro His
Tyr Arg Ser Phe
Tyr Arg Tyr Ala
Tyr Ser Phe Arg
Tyr Ser Arg Phe
Tyr Val Lys Tyr
Tyr Val Gln Tyr
Tyr Val Tyr Lys
Tyr Val Tyr Gln
Tyr Tyr Ala Arg
Tyr Tyr Ile Asn
Tyr Tyr Lys Val
Tyr Tyr Leu Asn
Tyr Tyr Asn Ile
Tyr Tyr Asn Leu
Tyr Tyr Gln Val
Tyr Tyr Arg Ala
Tyr Tyr Val Lys
Tyr Tyr Val Gln
Endomorphin-2
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
Butikacin
C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
Plocabulin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
3-cyclohexyl-1-[[(4R,5R)-8-[2-(3-fluorophenyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
(2R)-3-(3-chloro-4-hydroxyphenyl)-2-[[(E,3R,8S,9S,10R)-3,9-dihydroxy-2,4-dimethoxy-6,8,10-trimethyl-7-oxotetradec-5-enoyl]amino]propanoic acid
C28H42ClNO9 (571.2547952000001)
Arg-Phe-Phe-Cys
A tetrapeptide composed of L-arginine, two L-phenylalanine units and L-cysteine joined in sequence by peptide linkages.
3-cyclohexyl-1-[[(4S,5S)-8-[2-(3-fluorophenyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(4R,5S)-8-[2-(3-fluorophenyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(4S,5R)-8-[2-(3-fluorophenyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(4S,5R)-8-[2-(3-fluorophenyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(4S,5S)-8-[2-(3-fluorophenyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(4R,5S)-8-[2-(3-fluorophenyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(4R,5R)-8-[2-(3-fluorophenyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
2-hexadecanoyl-sn-glycero-3-phospho-(1D-myo-inositol)
N-[(2R,4aS,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(3-propan-2-ylanilino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-methoxybenzamide
C33H37N3O6 (571.2682222000001)
4-[3-[(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[(4-methyl-1-piperazinyl)-oxomethyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]benzonitrile
C32H37N5O3S (571.2616972000001)
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-[(4-phenoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-phenyl-1-piperazinyl)ethanone
C34H41N3O5 (571.3046056000001)
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-methylbenzenesulfonamide
4-[3-[(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[(4-methyl-1-piperazinyl)-oxomethyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]benzonitrile
C32H37N5O3S (571.2616972000001)
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-[(4-phenoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-phenyl-1-piperazinyl)ethanone
C34H41N3O5 (571.3046056000001)
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[(4-phenoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-phenyl-1-piperazinyl)ethanone
C34H41N3O5 (571.3046056000001)
2-amino-3-[[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
2-amino-3-[hydroxy-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxypropanoic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate
[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-pentanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-propanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate
1-hexadecanoyl-sn--glycero-3-phospho-D-myo-inositol(1-)
A 1-acyl-sn-glycero-3-phospho-1D-myo-inositol(1-) in which the acyl group is specified as hexadecanoyl (palmitoyl); major species at pH 7.3.
PC(21:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PE(24:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LPS(22:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
4-[(2s,3s)-2-(4,8-dimethylnona-3,7-dien-1-yl)-3,5-dihydroxy-2-methyl-7-oxo-3h,4h,9h-pyrano[2,3-e]isoindol-8-yl]-1,5-dimethyl-2-phenylpyrazol-3-one
C34H41N3O5 (571.3046056000001)
(2s)-n-[(3z,6s,9s,12r,13r)-3-ethylidene-5,8,11-trihydroxy-9-isopropyl-6,13-dimethyl-2-oxo-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-12-yl]-2-{[(2s)-3-oxobutan-2-yl]amino}-3-phenylpropanimidic acid
14-o-anisoylneoline
{"Ingredient_id": "HBIN001537","Ingredient_name": "14-o-anisoylneoline","Alias": "NA","Ingredient_formula": "C32H45NO8","Ingredient_Smile": "CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6CC4C5C6OC(=O)C7=CC=C(C=C7)OC)OC)O)OC)O)COC","Ingredient_weight": "571.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14317","TCMID_id": "1292","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "12068477","DrugBank_id": "NA"}
(2r,3s,4r,5r,6s,8s,13r,14r,16s,17s,18r)-5,14-dihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-7-oxo-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate
3,4,5,8,11-pentahydroxy-13-(3h-imidazol-4-ylmethyl)-7-[(4-methoxyphenyl)methyl]-10-(sec-butyl)-1h,2h,3h,4h,4ah,7h,10h,13h-pyridazino[1,6-a]1,4,7,10-tetraazacyclododecan-14-one
(1s,2r,3r,4s,5r,6s,8r,9r,10r,13s,16s,17r,18r)-11-ethyl-8,18-dihydroxy-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 4-methoxybenzoate
{6-[5-(5-{[4-(acetyloxy)-1-hydroxypent-2-en-1-ylidene]amino}-3,6-dimethyloxan-2-yl)-3-methylpenta-1,3-dien-1-yl]-4-(chloromethyl)-4,5-dihydroxyoxan-2-yl}acetic acid
C28H42ClNO9 (571.2547952000001)
(3r,4s,4as,7s,10r,13s)-10-[(2s)-butan-2-yl]-3,4,5,8,11-pentahydroxy-13-(3h-imidazol-4-ylmethyl)-7-[(4-methoxyphenyl)methyl]-1h,2h,3h,4h,4ah,7h,10h,13h-pyridazino[1,6-a]1,4,7,10-tetraazacyclododecan-14-one
(1s,3r,4s,5r,8s,9r,10r,11r,14r,16s,17s,18s,19s)-4,10,19-tris(acetyloxy)-9-hydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl (2r)-2-methylbutanoate
(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16r,17r,18s)-11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate
(2s)-n-[(3z,6s,9s,12r,13r)-3-ethylidene-5,8,11-trihydroxy-9-isopropyl-6,13-dimethyl-2-oxo-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-12-yl]-2-{[(2r)-3-oxobutan-2-yl]amino}-3-phenylpropanimidic acid
4,10,19-tris(acetyloxy)-9-hydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl 2-methylbutanoate
3-{1-[(13z)-8,11-dihydroxy-16-methoxy-10-(sec-butyl)-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,16-pentaen-6-yl]-3-methyl-1-oxobutan-2-yl}-1,5-dimethylimidazolidin-4-one
(7s,10r,13r)-10-[(2r)-butan-2-yl]-3,4,5,8,11-pentahydroxy-13-(3h-imidazol-4-ylmethyl)-7-[(4-methoxyphenyl)methyl]-1h,2h,3h,4h,4ah,7h,10h,13h-pyridazino[1,6-a]1,4,7,10-tetraazacyclododecan-14-one
(1s,2r,3r,4s,5r,6s,8r,9s,13s,16s,17r,18r)-11-ethyl-8,16-dihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 4-methoxybenzoate
[(2s,4s,5r,6r)-6-[(1e,3e)-5-[(2s,3s,5r,6r)-5-{[(2z,4s)-4-(acetyloxy)-1-hydroxypent-2-en-1-ylidene]amino}-3,6-dimethyloxan-2-yl]-3-methylpenta-1,3-dien-1-yl]-4-(chloromethyl)-4,5-dihydroxyoxan-2-yl]acetic acid
C28H42ClNO9 (571.2547952000001)